12/16/2024 4:15 PM | Petros Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2024 3:57 PM | Petros Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/18/2024 3:21 PM | Petros Pharmaceuticals (Filer)
| Form DEFA14A | |
11/13/2024 4:11 PM | Petros Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024 10:14 AM | INTRACOASTAL CAPITAL, LLC (Filed by) Petros Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/25/2024 4:00 PM | Petros Pharmaceuticals (Filer)
| Form DEF 14A | |
10/25/2024 4:02 PM | Petros Pharmaceuticals (Filer)
| Form ARS | |
|
10/18/2024 4:00 PM | Petros Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2024 4:07 PM | Petros Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/15/2024 4:19 PM | Petros Pharmaceuticals (Filer)
| Form PRE 14A | |
10/04/2024 4:15 PM | Petros Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/19/2024 3:05 PM | Petros Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2024 11:15 PM | Petros Pharmaceuticals (Filer)
| Form EFFECT | |
05/15/2024 4:00 PM | Petros Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/01/2024 3:31 PM | Petros Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/22/2024 3:31 PM | Petros Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 2:38 PM | Ayrton Capital LLC (Filed by) Petros Pharmaceuticals (Subject)
| Form SC 13G | |
02/06/2024 9:23 AM | INTRACOASTAL CAPITAL, LLC (Filed by) Petros Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/12/2024 3:32 PM | Petros Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/28/2023 3:05 PM | Petros Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/26/2023 4:05 PM | Bradley Greg (Reporting) Petros Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 4:06 PM | Petros Pharmaceuticals (Issuer) Silverman Joshua (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 4:06 PM | Arnold Mitchell (Reporting) Petros Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 4:07 PM | Petros Pharmaceuticals (Issuer) WALKER WAYNE REMELL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 4:07 PM | Boctor Fady (Reporting) Petros Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 4:08 PM | Bernstein Bruce (Reporting) Petros Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |